These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 140543)

  • 61. Recovery kinetics of epidermal cell proliferation after two intraperitoneal injections of epidermal extracts (chalone).
    Iversen OH
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(2):201-7. PubMed ID: 6139910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin.
    Garcia AA; Muggia FM; Spears CP; Jeffers S; Silberman H; Pujari M; Koda RT
    Anticancer Drugs; 2001 Jul; 12(6):505-11. PubMed ID: 11459996
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
    Kaubisch A; Kaleya R; Haynes H; Rozenblit A; Wadler S
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):337-40. PubMed ID: 14704829
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.
    Komatsu N; Okubo S; Kikumoto S; Kimura K; Saito G
    Gan; 1969 Apr; 60(2):137-44. PubMed ID: 5810959
    [No Abstract]   [Full Text] [Related]  

  • 65. Cell cycle synchronization of the mouse S-180 tumor following alternating period of hydroxyurea-blockade and release.
    Tomita K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Nov; 53(11):1687-95. PubMed ID: 528803
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peripheral blood lymphocyte nucleoli of rats with Yoshida ascitic sarcoma and the effect of cyclophosphamide.
    Matĕjková E
    Folia Biol (Praha); 1975; 21(5):349-53. PubMed ID: 1201807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Substances with antineoplastic effect. XLII. The influence of MBA on incorporation of some amino-acids in the proteins of Yoshida ascites rat sarcoma cells.
    Veselá H; Kraus P; Semonský M; Slavíková V
    Neoplasma; 1970; 17(1):49-52. PubMed ID: 5423433
    [No Abstract]   [Full Text] [Related]  

  • 69. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytolytic activity of cytotoxin isolated from Indian cobra venom against experimental tumor cells.
    Iwaguchi T; Takechi M; Hayashi K
    Biochem Int; 1985 Mar; 10(3):343-9. PubMed ID: 4015662
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of hydroxyurea and vinblastine on the proliferation of the pluripotential stem cells.
    Necas E; Neuwirt J
    Neoplasma; 1977; 24(1):29-40. PubMed ID: 840337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.
    Beitler JJ; Smith RV; Haynes H; Silver CE; Quish A; Kotz T; Serrano M; Brook A; Wadler S
    Invest New Drugs; 1998; 16(2):161-9. PubMed ID: 9848580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Affinity of intraperitoneally injected activated carbon particles adsorbing mitomycin C to tumor surface of Yoshida sarcoma.
    Hagiwara A; Takahashi T; Iwamoto A; Yoneyama C; Itoh M; Sasabe T
    Anticancer Drug Des; 1990 Nov; 5(4):359-69. PubMed ID: 2127181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of branched chain amino acid-enriched total parenteral nutrition on amino acid utilization in rats bearing Yoshida sarcoma.
    Crosby LE; Bistrian BR; Ling PR; Istfan NW; Blackburn GL; Hoffman SB
    Cancer Res; 1988 May; 48(10):2698-702. PubMed ID: 3129186
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of trenimon on single phases of the cell cycle of Yoshida ascites tumor cells (author's transl)].
    Liss E; Averdunk R; Jungwirth T; Palme G
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):315-24. PubMed ID: 136106
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (2) Concentrations within the tumors and normal tissues and therapeutic and adverse effects of 5-fluorouracil delivered by various routes].
    Ota J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2362-9. PubMed ID: 6639098
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [On the study of the implantation of ascites tumor in urinary bladder. IV. Effect of antitumor agents (1)].
    Suzuki K; Sugita A; Miura T; Kato M; Onodera Y
    Nihon Hinyokika Gakkai Zasshi; 1967 Oct; 58(10):1003-9. PubMed ID: 4296284
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacokinetic modulation of plasma 5-fluorouracil concentrations to potentiate the antitumor activity of continuous venous infusion of 5-fluorouracil.
    Fujii S; Fukushima M; Shimamoto Y; Shirasaka T
    Jpn J Cancer Res; 1989 Jun; 80(6):509-12. PubMed ID: 2503471
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of the effect of hydroxyurea on stem cell (CFU-s) kinetics.
    Necas E; Hauser F
    Cell Tissue Kinet; 1982 Jan; 15(1):39-47. PubMed ID: 7060081
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA synthesis in tumor-bearing rats: purification of liver thymidine kinase stimulating factor from Yoshida sarcoma.
    Harada N; Shirasaka T; Fujii S
    Gan; 1980 Apr; 71(2):173-80. PubMed ID: 7202914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.